GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Level Biotechnology Inc (ROCO:3118) » Definitions » EV-to-FCF

Level Biotechnology (ROCO:3118) EV-to-FCF : 13.88 (As of Jun. 05, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Level Biotechnology EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Level Biotechnology's Enterprise Value is NT$696.6 Mil. Level Biotechnology's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was NT$50.2 Mil. Therefore, Level Biotechnology's EV-to-FCF for today is 13.88.

The historical rank and industry rank for Level Biotechnology's EV-to-FCF or its related term are showing as below:

ROCO:3118' s EV-to-FCF Range Over the Past 10 Years
Min: 3.24   Med: 8.59   Max: 194.77
Current: 13.17

During the past 13 years, the highest EV-to-FCF of Level Biotechnology was 194.77. The lowest was 3.24. And the median was 8.59.

ROCO:3118's EV-to-FCF is ranked worse than
56.08% of 378 companies
in the Biotechnology industry
Industry Median: 8.345 vs ROCO:3118: 13.17

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-05), Level Biotechnology's stock price is NT$35.35. Level Biotechnology's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was NT$2.020. Therefore, Level Biotechnology's PE Ratio for today is 17.50.


Level Biotechnology EV-to-FCF Historical Data

The historical data trend for Level Biotechnology's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Level Biotechnology EV-to-FCF Chart

Level Biotechnology Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.15 7.53 3.49 7.66 8.54

Level Biotechnology Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.57 7.50 8.54 8.54 11.23

Competitive Comparison of Level Biotechnology's EV-to-FCF

For the Biotechnology subindustry, Level Biotechnology's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Level Biotechnology's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Level Biotechnology's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Level Biotechnology's EV-to-FCF falls into.



Level Biotechnology EV-to-FCF Calculation

Level Biotechnology's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=696.644/50.177
=13.88

Level Biotechnology's current Enterprise Value is NT$696.6 Mil.
Level Biotechnology's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$50.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Level Biotechnology  (ROCO:3118) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Level Biotechnology's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=35.35/2.020
=17.50

Level Biotechnology's share price for today is NT$35.35.
Level Biotechnology's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$2.020.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Level Biotechnology EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Level Biotechnology's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Level Biotechnology (ROCO:3118) Business Description

Traded in Other Exchanges
N/A
Address
No.80, Lane 169, Kangning Street, Hsi-Chih, New Taipei, TWN, 221
Level Biotechnology Inc is a Taiwan based company engages in the provision of biotechnological services. It offers cell culture, immune protein, gene nucleic acids, and molecular biology, and instruments and equipment. It offers preclinical trial services in the areas of mammalian toxicology, genetic toxicology, pharmacology, biocompatibility, and model animal production.

Level Biotechnology (ROCO:3118) Headlines

No Headlines